Literature DB >> 8806347

The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study Group.

H B Rubins1, S J Robins, D Collins.   

Abstract

This report describes the baseline characteristics of the 2,531 patients with coronary artery disease enrolled in the Veterans Affairs Cooperative Studies Program High Density Lipoprotein Intervention Trial. The population is characterized by a large percentage of elderly patients, diabetic patients, and patients with the clinical characteristics of the insulin-resistance syndrome.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8806347     DOI： 10.1016/s0002-9149(96)00369-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  6 in total

1.  Fibrate pharmacogenomics: expanding past the genome.

Authors:  John S House; Alison A Motsinger-Reif
Journal:  Pharmacogenomics       Date:  2020-03-17       Impact factor: 2.533

Review 2.  Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes.

Authors:  Ilaria Cavallari; Alessia Delli Veneri; Ernesto Maddaloni; Rosetta Melfi; Giuseppe Patti; Nicola Napoli; Paolo Pozzilli; Germano Di Sciascio
Journal:  Curr Diab Rep       Date:  2018-10-29       Impact factor: 4.810

Review 3.  Vascular biology, atherosclerosis, and implications for cardiac care.

Authors:  G S Berenson; S R Srinivasan; B Radhakrishnamurthy
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.967

Review 4.  Combination drug therapy for combined hyperlipidemia.

Authors:  J R Guyton
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 3.955

Review 5.  Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs.

Authors:  Michele d'Angelo; Vanessa Castelli; Maria Grazia Tupone; Mariano Catanesi; Andrea Antonosante; Reyes Dominguez-Benot; Rodolfo Ippoliti; Anna Maria Cimini; Elisabetta Benedetti
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

6.  PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

Authors:  Neerupma Silswal; Nikhil K Parelkar; Michael J Wacker; Mostafa Badr; Jon Andresen
Journal:  PPAR Res       Date:  2012-09-11       Impact factor: 4.964
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.